[go: up one dir, main page]

DK162255C - Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf - Google Patents

Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Info

Publication number
DK162255C
DK162255C DK254585A DK254585A DK162255C DK 162255 C DK162255 C DK 162255C DK 254585 A DK254585 A DK 254585A DK 254585 A DK254585 A DK 254585A DK 162255 C DK162255 C DK 162255C
Authority
DK
Denmark
Prior art keywords
plunger pipe
preparation
plate
damper
aural
Prior art date
Application number
DK254585A
Other languages
Danish (da)
English (en)
Other versions
DK254585D0 (da
DK254585A (da
DK162255B (da
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK254585D0 publication Critical patent/DK254585D0/da
Publication of DK254585A publication Critical patent/DK254585A/da
Publication of DK162255B publication Critical patent/DK162255B/da
Application granted granted Critical
Publication of DK162255C publication Critical patent/DK162255C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DK254585A 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf DK162255C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421613 1984-06-09
DE3421615 1984-06-09
DE3421613 1984-06-09
DE19843443877 DE3443877A1 (de) 1984-06-09 1984-12-01 Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
DE3443877 1984-12-01

Publications (4)

Publication Number Publication Date
DK254585D0 DK254585D0 (da) 1985-06-06
DK254585A DK254585A (da) 1985-12-10
DK162255B DK162255B (da) 1991-10-07
DK162255C true DK162255C (da) 1992-03-16

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254585A DK162255C (da) 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Country Status (16)

Country Link
EP (1) EP0166971B1 (es)
AT (1) ATE50502T1 (es)
AU (1) AU575951B2 (es)
CA (1) CA1258427A (es)
DE (1) DE3576120D1 (es)
DK (1) DK162255C (es)
ES (1) ES8605679A1 (es)
FI (1) FI80596C (es)
GR (1) GR851393B (es)
HU (1) HU200102B (es)
IE (1) IE57998B1 (es)
IL (1) IL75448A (es)
NO (1) NO164277C (es)
NZ (1) NZ212338A (es)
PH (1) PH24118A (es)
PT (1) PT80620B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
KR101820024B1 (ko) 2008-10-17 2018-01-18 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
LT2498801T (lt) 2009-11-13 2018-05-10 Sanofi-Aventis Deutschland Gmbh Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
PL3417871T3 (pl) 2009-11-13 2021-06-14 Sanofi-Aventis Deutschland Gmbh Kompozycja farmaceutyczna zawierająca agonistę GLP-1, insulinę i metioninę
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN110354255B (zh) 2013-04-03 2024-05-14 赛诺菲 通过长效胰岛素制剂治疗糖尿病
CA2970200A1 (en) 2014-12-12 2016-06-16 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CH650677A5 (de) * 1981-08-27 1985-08-15 Lilly Co Eli Gegen diabetes mellitus wirksames pharmazeutisches mittel.
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
NO164277B (no) 1990-06-11
IE57998B1 (en) 1993-06-02
FI852273A0 (fi) 1985-06-06
PH24118A (en) 1990-03-05
PT80620B (pt) 1987-10-20
CA1258427A (en) 1989-08-15
EP0166971B1 (de) 1990-02-28
AU4342485A (en) 1985-12-12
ES543972A0 (es) 1986-01-16
DK254585D0 (da) 1985-06-06
NO852314L (no) 1985-12-10
IE851431L (en) 1985-12-09
DK254585A (da) 1985-12-10
FI80596B (fi) 1990-03-30
NZ212338A (en) 1989-02-24
HUT37893A (en) 1986-03-28
PT80620A (de) 1985-07-01
ATE50502T1 (de) 1990-03-15
IL75448A0 (en) 1985-10-31
HU200102B (en) 1990-04-28
FI80596C (fi) 1990-07-10
ES8605679A1 (es) 1986-01-16
GR851393B (en) 1985-11-25
NO164277C (no) 1990-09-19
DE3576120D1 (de) 1990-04-05
AU575951B2 (en) 1988-08-11
FI852273L (fi) 1985-12-10
DK162255B (da) 1991-10-07
EP0166971A1 (de) 1986-01-08
IL75448A (en) 1989-07-31

Similar Documents

Publication Publication Date Title
DK162255C (da) Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf
KR880001454A (ko) 유체 충전 탄성중합체 댐핑장치
DK0702231T3 (da) Fremgangsmåde til pakning af chromatografikolonner
BE872678A (fr) Valve pour regler la circulation d'un fluide
IT1229760B (it) Analizzatore di fluidi con compensazione.
SE8900782D0 (sv) Anordning vid slaaende maskiner
DE69010781D1 (de) Vorrichtung für die Thoraxdrainage.
GB9026007D0 (en) Fluid filled elastomeric damping device
DE3867204D1 (de) Gummilager.
ES2048369T3 (es) Tratamiento de metal liquido.
BE881461A (fr) Dispositif de controle pour le liquide de refroidissement de compresseurs travaillant avec injection de liquide
ATE67015T1 (de) Schwingungsdaempfer fuer maschinenlagerungen.
IT1138611B (it) Valvola di ritegno per fluidi
ES2022298B3 (es) Estructura plastica resistente al fuego
SE8105745L (sv) Borttagbar tetning for askfickor och liknande
MY101782A (en) Method for removing a volatile material from a liquid and equipment for the working of this method
ES257901U (es) Cabeza tomamuestras para medidor de velocidad de sedimenta- cion de sangre
UA39943C2 (uk) Компенсатор енергії
SE8504611L (sv) Vattenpump
SE8603824L (sv) Leckageindikator
IT8041572A0 (it) Procedimento per determinare la profondita' di giacitura di uno strato saturo di fluido e il tipo di fluido.
SE8400668L (sv) Massageapparat
JPS57157843A (en) Mounting method of rebound rubber in damper
ES288427U (es) Molde para congelar liquidos
ES262731U (es) Soporte de motor de dos camaras con amortiguacion hidraulica.

Legal Events

Date Code Title Description
PUP Patent expired